Friday, July 07, 2006 12:41:21 PM
Welcome to the board read_this_n0w. I have been enjoying reading your posts on YMB. Nice work and thanks.
There is something coming next week either a PR or a coverage. I don't know the content of the news and don't know the exact date of the news.
With accepting of ophran status of iplex by EMEA, Insmed is to file NDA in EU in August. They have all data ready (some presentated in ENDO). Insmed also is looking for a partner in EU and co-clinic-trial partner in US to work its pipelines.
The Court patent pre-trial ruling on claim construction did a great damage to Insmed's stock price. The company believes they can still manufacture and sell iPlex. By the end of this year or earlier next, Insmed will use Pfenex to make room-temp-stable iPlex. Dowphrama owns patents to make iPlex proteins using pfenex. Dowphrama provides the same technology to CBM (Cambrex) to make Increlex.
No word about TRCA VA unfair lawsuit case. Seems like Insmed ignores the case. Hope someone who has PACER access can tell us something.
There is something coming next week either a PR or a coverage. I don't know the content of the news and don't know the exact date of the news.
With accepting of ophran status of iplex by EMEA, Insmed is to file NDA in EU in August. They have all data ready (some presentated in ENDO). Insmed also is looking for a partner in EU and co-clinic-trial partner in US to work its pipelines.
The Court patent pre-trial ruling on claim construction did a great damage to Insmed's stock price. The company believes they can still manufacture and sell iPlex. By the end of this year or earlier next, Insmed will use Pfenex to make room-temp-stable iPlex. Dowphrama owns patents to make iPlex proteins using pfenex. Dowphrama provides the same technology to CBM (Cambrex) to make Increlex.
No word about TRCA VA unfair lawsuit case. Seems like Insmed ignores the case. Hope someone who has PACER access can tell us something.
Recent INSM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:41:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 08:01:21 PM
- Insmed Provides Clinical Update on Phase 2b CEDAR Study • PR Newswire (US) • 04/07/2026 08:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/06/2026 08:42:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:07:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/01/2026 09:10:46 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/01/2026 08:03:54 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/01/2026 08:02:49 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/01/2026 08:01:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:13:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/30/2026 09:31:03 PM
- Insmed shares rise after UTHR trial data and Morgan Stanley upgrade • IH Market News • 03/30/2026 03:04:13 PM
- Insmed shares rise on positive results from ARIKAYCE Phase 3b study • IH Market News • 03/23/2026 02:34:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:00:30 AM
- Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease • PR Newswire (US) • 03/23/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 08:05:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/19/2026 08:57:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:59:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:16:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:15:10 PM
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 03/05/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:14:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2026 09:04:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2026 09:04:19 PM

